FT Global Pharmaceutical and Biotechnology Conference

Date: 3 – 4 December 2013
Location: The InterContinental Park Lane, London

The FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives, ‘feel the pulse’ of the industry, and network with peers across the sector.

Chaired by Andrew Jack, Pharmaceutical Correspondent at the Financial Times and Reynold W. (Pete) Mooney, Global Leader, Life Sciences and Health Care, Deloitte speakers already joining us include:

• Pascal Soriot, Chief Executive Officer, AstraZeneca
• Daniel O’Day, Chief Operating Officer, Pharmaceuticals, Roche
• Marijn Dekkers, Chairman of the Board of Directors, Bayer
• Joerg Reinhardt, Chairman-Elect of the Board of Directors, Novartis
• Richard Bergström, Director General, European Association of Pharmaceutical Industries and Associations (EFPIA)
• Ayman Sahli, Chief Executive Officer, Julphar – Gulf Pharmaceutical Industries
• Nikos Dedes, Chair, Positive Voice, Greece & Member of the EMA Management Board
• David Stuckler, Senior Research Fellow, Oxford University, Author: The Body Economic: Why Austerity Kills
• Edward Abrahams, President, Personalized Medicine Coalition
• Paul Stoffels, Chief Scientific Officer, Worldwide Chairman, Pharmaceuticals, Johnson & Johnson

For the full agenda and speaker line-up please visit the website: www.ft-live.com/pharmabio2013

For enquiries or further information please contact Zowie Fort on +44 (0)207 775 6653 or [email protected]